Millstone Evans Group’s Chemours CC Stock Holding History

Millstone Evans Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-125	Closed	-$2.11K	–	799
2024 Q4	$2.11K	Buy	+125	New	+$2.43K	﹤0.01%	645

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Millstone Evans Group's CC Position: Q1 2025 in Review

Millstone Evans Group sold out of Chemours (CC) in Q1 2025, closing a stake of 125 shares — an estimated $2.11K sold.

Millstone Evans Group first reported a position in CC in Q4 2024 and held it in 1 quarter. The position peaked at $2.11K in Q4 2024. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

Millstone Evans Group reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
Millstone Evans Group sold 125 Chemours shares in Q1 2025, an estimated $2.11K.
Millstone Evans Group first reported a position in Chemours in Q4 2024 and held it in 1 quarter.
Millstone Evans Group's Chemours position peaked at $2.11K in Q4 2024.
419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on Millstone Evans Group's 13F filing for Q1 2025, filed 5 May 2025.